Inhibition of neuronal necroptosis via disruption of RIPK1-RIPK3 Interactions: The role of neural stem cell-derived exosomes in spinal cord injury recovery

Authors:

Abstract
Spinal cord injury (SCI) poses a significant economic and public health burden. Exosomes derived from neural stem cells (NSC-Exos) are emerging as a promising therapeutic strategy for SCI repair, overcoming several limitations associated with both autologous and allogeneic neural stem cell therapies. This study demonstrates that NSC-Exos are efficiently internalized by the injured spinal cord after co-injection, resulting in substantial motor function recovery in murine models. Additionally, NSC-Exos effectively limit the expansion of the injury site, reduce neuronal degeneration, and attenuate neuroinflammatory responses. Notably, this is the first study to identify necroptosis as a novel therapeutic target for NSC-Exos in SCI recovery. We show that NSC-Exos inhibit neuronal necroptosis both in vivo and in vitro by disrupting the RIPK1-RIPK3 interaction, thereby preventing necrosome assembly. Furthermore, comprehensive transcriptomic analysis reveals that the ubiquitin-mediated proteolysis (UPS) pathway plays a crucial role in this process, a finding supported by experimental inhibition of ubiquitination. In conclusion, this study highlights the therapeutic potential of NSC-Exos in SCI treatment, particularly through the inhibition of necroptosis via disruption of the RIPK1-RIPK3 interaction, potentially involving UPS activation. These findings provide a foundation for future investigations into the molecular mechanisms underlying SCI recovery.
Funding Information
  • Guangdong Provincial Key Laboratory for Translational Cancer Research of Chinese Medicine, Guangzhou University of Chinese Medicine (ZDSYS20230626091402006)
  • Science, Technology and Innovation Commission of Shenzhen Municipality (20231800939902)
  • Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20230807110259002)
  • Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20230807110310021)
  • National Natural Science Foundation of China (82402846)
  • National Natural Science Foundation of China (81801907)
  • Shenzhen Science and Technology Innovation Program
  • Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515140171)
  • China Postdoctoral Science Foundation (GZC20242074)
  • China Postdoctoral Science Foundation (2024M763788)
  • Major Program of National Fund of Philosophy and Social Science of China
  • Adolph C. and Mary Sprague Miller Institute for Basic Research in Science, University of California Berkeley

This publication has 64 references indexed in Scilit: